Content
63%Weight 40%Scale 1-5Reviews the quality of instructions and guidance provided to agents. Good implementation is clear, handles edge cases, and produces reliable results.
The body delivers a well-sequenced, highly actionable 8-phase workflow with tool parameters, fallbacks, evidence grading, and a completeness checklist. Its weaknesses are redundant framing/summary sections that pad the token cost, and progressive disclosure that is well designed on paper but broken in practice because every referenced detail file is missing from the bundle.
Suggestions
Ship the referenced bundle files (phase-procedures-detailed.md, report-templates.md, evidence-grading.md, phase-details.md, test_skill.py) or remove/trim the dangling references so progressive disclosure actually works.
Delete the redundant framing: the generic "Comprehensive chemical safety analysis integrating..." sentence, the "When to Use This Skill" triggers section (duplicates the frontmatter description), and the closing Summary section — this tightens conciseness without losing guidance.
Add an explicit validation step to the batch screening workflow (e.g., check SMILES validity in Phase 0 before batch prediction), since invalid SMILES are called out as a known ADMET-AI failure mode under Limitations.
| Dimension | Reasoning | Score |
|---|---|---|
Conciseness | Mostly dense and useful (tool signatures with parameter types, fallbacks, limitations), but there is noticeable slack: the generic sentence "Comprehensive chemical safety analysis integrating predictive AI models, curated toxicogenomics databases, regulatory safety data, and chemical-biological interaction networks" restates the frontmatter description, the "When to Use This Skill" triggers section largely duplicates the description's triggers, and the closing "Summary" section (Total tools / Best for / Outputs) repeats earlier content. Fits 'mostly efficient but includes some unnecessary explanation or could be tightened' better than the score-4 'minor instances' anchor, though not the 'several padded sections' of score 2. | 3 / 5 |
Actionability | Concrete, executable guidance throughout: tool calls with exact parameter names and types ("ADMETAI_predict_toxicity (`smiles`: list[str])"), install dependency note ("pip install tooluniverse[ml]"), fallback tools for failures, and live-verified response shapes for DrugProps tools. Minor gaps keep it below the copy-paste-ready score-5 anchor: some tool names are elided with shorthand ("FDA_get_boxed_warning_info_by_drug_name / _contraindications_ / _adverse_reactions_"), and there is no worked end-to-end example for a common case. | 4 / 5 |
Workflow Clarity | The 8-phase sequence is explicit (ASCII pipeline plus per-phase tool lists) with real checkpoints: Phase 0 disambiguation always first, a Mandatory Completeness Checklist, "No data" handling, and fallback strategies for failed tools (STITCH → STRING, ADMET-AI unavailable → CTD/PubChemTox). Below score 5 because full decision logic and error-recovery detail is delegated to phase-procedures-detailed.md, and the batch screening pattern has no explicit validation step despite "Invalid SMILES cause ADMET-AI failures" being a known failure mode listed under Limitations — minor validation gaps matching the score-4 anchor. | 4 / 5 |
Progressive Disclosure | The design is good — an overview body with clearly signaled one-level-deep references ("See phase-procedures-detailed.md", a dedicated Reference Files section) — but the bundle contains no reference files at all: phase-procedures-detailed.md, report-templates.md, evidence-grading.md, phase-details.md, and test_skill.py are all absent, so the references dangle and the disclosure structure cannot actually function. Per the guideline to score against the actual bundle structure, this falls to 'some structure but could be better organized' rather than the score-4 'most content appropriately placed' anchor. | 3 / 5 |
Total | 14 / 20 Passed |